GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » Price-to-Free-Cash-Flow

Chandra Bhagat Pharma (BOM:542934) Price-to-Free-Cash-Flow : 13.52 (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma Price-to-Free-Cash-Flow?

As of today (2024-05-15), Chandra Bhagat Pharma's share price is ₹120.25. Chandra Bhagat Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₹8.89. Hence, Chandra Bhagat Pharma's Price-to-Free-Cash-Flow Ratio for today is 13.52.

The historical rank and industry rank for Chandra Bhagat Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:542934' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.6   Med: 8.17   Max: 22.77
Current: 13.43

During the past 7 years, Chandra Bhagat Pharma's highest Price-to-Free-Cash-Flow Ratio was 22.77. The lowest was 3.60. And the median was 8.17.

BOM:542934's Price-to-Free-Cash-Flow is ranked better than
70.32% of 502 companies
in the Drug Manufacturers industry
Industry Median: 22.88 vs BOM:542934: 13.43

Chandra Bhagat Pharma's Free Cash Flow per Share for the six months ended in Sep. 2023 was ₹-3.21. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹8.89.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Chandra Bhagat Pharma was 9.90% per year.

During the past 7 years, Chandra Bhagat Pharma's highest 3-Year average Free Cash Flow per Share Growth Rate was 44.80% per year. The lowest was -2.70% per year. And the median was 21.05% per year.


Chandra Bhagat Pharma Price-to-Free-Cash-Flow Historical Data

The historical data trend for Chandra Bhagat Pharma's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma Price-to-Free-Cash-Flow Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - 3.60 6.98 14.95

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 6.98 - 14.95 -

Competitive Comparison of Chandra Bhagat Pharma's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chandra Bhagat Pharma's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chandra Bhagat Pharma's Price-to-Free-Cash-Flow falls into.



Chandra Bhagat Pharma Price-to-Free-Cash-Flow Calculation

Chandra Bhagat Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=120.25/8.891
=13.52

Chandra Bhagat Pharma's Share Price of today is ₹120.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chandra Bhagat Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was ₹8.89.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Chandra Bhagat Pharma  (BOM:542934) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Chandra Bhagat Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Chandra Bhagat Pharma (BOM:542934) Business Description

Traded in Other Exchanges
N/A
Address
Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma (BOM:542934) Headlines

No Headlines